Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice

Diabetes

Volumn 48, Issue 2, 1999, Pages 377-382

  Flyvbjerg, Allan ^a   Bennett, William F ^c   Rasch, Ruth ^b   Kopchick, John J ^d   Scarlett, John A ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c Sensus Drug Development Corporation   (United States)

^d OHIO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GROWTH HORMONE RECEPTOR; HORMONE RECEPTOR BLOCKING AGENT; SOMATOMEDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH RETARDATION; HYPERGLYCEMIA; HYPERPHAGIA; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; STREPTOZOCIN DIABETES; URINARY EXCRETION;

ALBUMINURIA; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GROWTH HORMONE; HYPERTROPHY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; KIDNEY GLOMERULUS; LIVER; MICE; MICE, INBRED BALB C; ORGAN SIZE; POLYETHYLENE GLYCOLS; RECEPTORS, SOMATOTROPIN;

EID: 0033047377     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.2.377     Document Type: Article

References (48)

1. Deckert T, Poulsen JE, Larsen M: Prognosis of diabetics with diabetes onset before age of thirty-one. Diabetologia 14:363-370, 1978
2. Viberty GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet i:1430-1432, 1982
3. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984
4. Borch-Johnsen K, Kreiner S: a: value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. BMJ 294:1651-1654, 1987
5. Flyvbjerg A: Growth factors and diabetic complications. Diabet Med 7:387-399, 1990
6. Flyvbjerg A, Frystyk J, Sillesen IB, Ørskov H: Growth hormone and insulin-like growth factor I in experimental and human diabetes. In Diabetes Annual/6. Alberti KGMM, Krall LP, Eds. Amsterdam, Elsevier, 1991, p. 562-590
7. Flyvbjerg A, Ørskov H, Alberti KGMM (Eds.): Growth Hormone and Insulin-Like Growth Factor I in Human and Experimental Diabetes. Chichester, Wiley, 1993, p. 1-322
8. Flyvbjerg A, Alberti KGMM, Froesch ER, De Meyts P, von zür Mühlen A, Ørskov H (Eds.): International symposium on glucose metabolism and growth factors. Metabolism 44 (Suppl. 4): 1-123, 1995
9. Flyvbjerg A: Role of growth hormone, insulin-like growth factors (IGFs), and IGF-binding proteins in the renal complications of diabetes. Kidney Int 52 (Suppl. 60):S12-S19, 1997
10. Flyvbjerg A, Grønbaæk H, Christiansen T, Bak M, Nielsen B, Vogel I, Hill C, Logan A, Ørskov H: The role of growth factors in the renal complications of diabetes. In Diabetes Annual/11. Marshall SM, Krall LP, Home PD, Eds. Amsterdam, Elsevier, 1998, p. 35-47
11. Flyvbjerg A, Frystyk J, Østerby R, Ørskov H: Kidney IGF-I and renal hypertrophy in GH-deficient dwarf rats. Am J Physiol 262:E956-E962, 1992
12. Grønbæk H, Volmers P, Bjørn SF, Østerby R, Ørskov H, Flyvbjerg A: Effect of isolated GH and IGF-I deficiency on long-term renal changes and urinary albumin excretion in streptozotocin diabetic dwarf rats. Am J Physiol 272:E918-E924, 1997
13. Flyvbjerg A, Frystyk J, Thorlacius-Ussing O, Ørskov H: Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 32:261-265, 1989
14. Flyvbjerg A, Marshall SM, Frystyk J, Hansen KW, Harris AG, Ørskov H: Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion. Kidney Int 41:805-812, 1992
15. Grønbæk H, Nielsen B, Frystyk J, Flyvbjerg A, Ørskov H: Effect of lanreotide, a somatostatin analogue, on diabetic renal hypertrophy, kidney and serum IGF-I and IGF-binding proteins. Exp Nephrol 4:295-303, 1996
16. Grønbæk H, Nielsen B, Frystyk J, Ørskov H, Flyvbjerg A: Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention. J Endocrinol 147:95-102, 1995
17. Grønbæk H, Nielsen B, Østerby R, Harris AG, Ørskov H, Flyvbjerg A: Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats. Diabetologia 38:135-144, 1995
18. Grønbæk H, Vogel I, Lancranjan I, Flyvbjerg A, Ørskov H: Effect of octreotide, captopril, or insulin on manifest long-term experimental diabetic renal changes. Kidney Int 53:56-61, 1998
19. Flyvbjerg A, Thorlacius-Ussing O, Næraa R, Ingerslev J, Ørskov H: Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 31:310-314, 1988
20. Flyvbjerg A, Ørskov H: Kidney tissue insulin-like growth factor I and initial renal growth in diabetic rats: relation to severity of diabetes. Acta Endocrinol (Copenh) 122:374-378, 1990
21. Segev Y, Landau D, Marbach M, Schadeh N, Flyvbjerg A, Phillip M: Renal hypertrophy in hyperglycemic nonobese diabetic (NOD) mice is associated with persistent renal accumulation of insulin-like growth factor (IGF) I. J Am Soc Nephrol 8:436-444, 1997
22. Flyvbjerg A, Bornfeldt KE, Ørskov H, Arnqvist HJ: Effect of insulin-like growth factor I infusion on renal hypertrophy in experimental diabetes mellitus in rats. Diabetologia 34:715-720, 1991
23. Flyvbjerg A, Bornfeldt KE, Marshall SM, Arnqvist HJ, Ørskov H: Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia 33:334-338, 1990
24. Flyvbjerg A, Kessler U, Dorka B, Funk B, Ørskov H, Kiess W: Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia 35:589-593, 1992
25. Landau D, Chin E, Bondy C, Domené H, Roberts CT Jr, Grønbæk H, Flyvbjerg A, LeRoith D: Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes. Endocrinology 136:1835-1842, 1995
26. Chen WY, Wight DC, Mehta BV, Wagner TE, Kopchick JJ: Glycine 119 of bovine growth hormone is critical for growth-promoting activity. Mol Endocrinol 5:1845-1852, 1991
27. Fun G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA: Rational design of potent antagonists to the human growth hormone receptor. Science 256:1677-1680, 1992
28. Ross C, Olsen K, Fuh G, Marian M, Mortensen D, Teshima G, Chang S, Chu H, Mukku V, Canova-Davis E, Somers T, Cronin M, Winkler M, Wells JA: Long-acting growth hormones produced by conjugation with polyethylene glycol. J Biol Chem 271:21969-21977
29. Ørskov H, Thomson HG, Yde H: Wick-chromatography for rapid and reliable immunoassay of insulin, glucagon, and growth hormone. Nature 219:193-195, 1968
30. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M: Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138-143, 1986
31. Weibel ER: Stereopological Methods: Practical Methods for Biological Morphometry. London, Academic, 1979, p. 51-57
32. Pagtalunan ME, Rasch R, Rennke HG, Meyer TW: Morphometric analysis of effects of angiotensin II on glomerular structure in rats. Am J Physiol 268:F82-F88, 1995
33. Takahashi K, Daughaday WH, Kipnis DM: Regulation of immunoreactive growth hormone secretion in male rats. Endocrinology 88:909-917, 1971
34. Chen WY, Wight DC, Wagner TE, Kopchick JJ: Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice. Proc Natl Acad Sci U S A 87:5061-5065, 1990
35. Chen WY, Wight DC, Chen N-Y, Coleman TA, Wagner TE, Kopchick JJ: Mutations in the third a-helix of bovine growth hormone dramatically affect its intracellular distribution in vitro and growth enhancement in transgenic mice. J Biol Chem 266:2252-2258, 1991
36. Chen WY, White ME, Wagner TE, Kopchick JJ: Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice. Endocrinology 129:1402-1408, 1991
37. Chen N-Y, Chen WY, Bellush L, Yang CW, Striker LJ, Striker GE, Kopchick JJ: Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice. Endocrinology 136:660-667, 1995
38. Chen N-Y, Chen WY, Kopchick JJ: A growth hormone antagonist protects mice against streptozotocin-induced glomerulosclerosis even in the presence of elevated levels of glucose and glycated hemoglobin. Endocrinology 137:5163-5165, 1996
39. Esposito C, Liu ZH, Striker GE, Phillips C, Chen N-Y, Chen WY, Kopchick JJ, Striker LJ: Inhibition of diabetic nephropathy by a GH antagonist: a molecular analysis. Kidney Int. 50:506-514, 1996
40. Tannenbaum GS: Growth hormone secretion dynamics in streptozotocin diabetes: evidence of a role for endogenous somatostatin. Endocrinology 108:76-82, 1981
41. Robinson ICAF, Clark RG, Carlsson LMS: Insulin, IGF-I, and growth in diabetic rats (Letter). Nature 326:549, 1987
42. Yde H: Abnormal growth hormone response to ingestion of glucose in juvenile diabetes. Acta Med Scand 186:499-504, 1969
43. Hansen AaP, Johansen K: Diurnal pattern of blood glucose, serum FFA, insulin, glucagon, and growth hormone in normals and juvenile diabetics. Diabetologia 6:27-33, 1970
44. Hansen AaP: Serum growth hormone patterns in juvenile diabetes. Dan Med Bull 19 (Suppl. 1):1-36, 1972
45. Landau D, Segev Y, Eshet R, Flyvbjerg A, Phillip M: Growth hormone (GH)-IGF-I axis changes associated with renal hypertrophy in nonobese diabetic (NOD) mice imitate human disease (Abstract). J Am Soc Nephrol 8:A2990, 1997
46. Massa G, Verhaeghe J, Vanderschueren-Lodweyckx M, Bouillon R: Normalization of decreased plasma concentrations of growth hormone-binding protein by insulin treatment in spontaneously diabetic BB rats. Horm Metab Res 25:325-326, 1993
47. Maes M, Ketelslegers J-M, Underwood LE: Low plasma somatomedin-C in streptozotocin-induced diabetes mellitus: correlation with changes in somatogenic and lactogenic liver-binding sites. Diabetes 32:1060-1069, 1983
48. Bornfeldt KE, Arnqvist HJ, Enberg B, Mathews LS, Norstedt G: Regulation of insulin-like growth factor I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. J Endocrinol 122:651-656, 1989